Literature DB >> 19419964

Syk tyrosine 317 negatively regulates osteoclast function via the ubiquitin-protein isopeptide ligase activity of Cbl.

Wei Zou1, Jennifer L Reeve, Haibo Zhao, F Patrick Ross, Steven L Teitelbaum.   

Abstract

Cytoskeletal organization of the osteoclast (OC), which is central to the capacity of the cell to resorb bone, is induced by occupancy of the alphavbeta3 integrin or the macrophage colony-stimulating factor (M-CSF) receptor c-Fms. In both circumstances, the tyrosine kinase Syk is an essential signaling intermediary. We demonstrate that Cbl negatively regulates OC function by interacting with Syk(Y317). Expression of nonphosphorylatable Syk(Y317F) in primary Syk(-/-) OCs enhances M-CSF- and alphavbeta3-induced phosphorylation of the cytoskeleton-organizing molecules, SLP76, Vav3, and PLCgamma2, to levels greater than wild type, thereby accelerating the resorptive capacity of the cell. Syk(Y317) suppresses cytoskeletal organization and function while binding the ubiquitin-protein isopeptide ligase Cbl. Consequently, Syk(Y317F) abolishes M-CSF- and integrin-stimulated Syk ubiquitination. Thus, Cbl/Syk(Y317) association negatively regulates OC function and therefore is essential for maintenance of skeletal homeostasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19419964      PMCID: PMC2707246          DOI: 10.1074/jbc.M109.012385

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.

Authors:  S Takeshita; K Kaji; A Kudo
Journal:  J Bone Miner Res       Date:  2000-08       Impact factor: 6.741

2.  Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1.

Authors:  G Levkowitz; H Waterman; S A Ettenberg; M Katz; A Y Tsygankov; I Alroy; S Lavi; K Iwai; Y Reiss; A Ciechanover; S Lipkowitz; Y Yarden
Journal:  Mol Cell       Date:  1999-12       Impact factor: 17.970

3.  DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk.

Authors:  Wei Zou; Jennifer L Reeve; Yuli Liu; Steven L Teitelbaum; F Patrick Ross
Journal:  Mol Cell       Date:  2008-08-08       Impact factor: 17.970

4.  Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts.

Authors:  K P McHugh; K Hodivala-Dilke; M H Zheng; N Namba; J Lam; D Novack; X Feng; F P Ross; R O Hynes; S L Teitelbaum
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

5.  Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain.

Authors:  T M Yankee; L M Keshvara; S Sawasdikosol; M L Harrison; R L Geahlen
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

6.  Point mutation of a tyrosine in the linker region of Syk results in a gain of function.

Authors:  K Sada; J Zhang; R P Siraganian
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

7.  The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo.

Authors:  Hyun-Ju Kim; Kaihua Zhang; Lihong Zhang; F Patrick Ross; Steven L Teitelbaum; Roberta Faccio
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

8.  Phospholipase Cgamma2 modulates integrin signaling in the osteoclast by affecting the localization and activation of Src kinase.

Authors:  Holly Epple; Viviana Cremasco; Kaihua Zhang; Dailing Mao; Gregory D Longmore; Roberta Faccio
Journal:  Mol Cell Biol       Date:  2008-03-31       Impact factor: 4.272

9.  Novel pro-survival functions of the Kruppel-like transcription factor Egr2 in promotion of macrophage colony-stimulating factor-mediated osteoclast survival downstream of the MEK/ERK pathway.

Authors:  Elizabeth W Bradley; Ming M Ruan; Merry J Oursler
Journal:  J Biol Chem       Date:  2008-01-15       Impact factor: 5.157

Review 10.  Tyrosine kinase SYK: essential functions for immunoreceptor signalling.

Authors:  M Turner; E Schweighoffer; F Colucci; J P Di Santo; V L Tybulewicz
Journal:  Immunol Today       Date:  2000-03
View more
  6 in total

1.  Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data.

Authors:  Brendan Boyce; Lianping Xing
Journal:  Clin Investig (Lond)       Date:  2011-12-01

Review 2.  Signaling networks regulating leukocyte podosome dynamics and function.

Authors:  Athanassios Dovas; Dianne Cox
Journal:  Cell Signal       Date:  2011-02-20       Impact factor: 4.315

3.  Tyrosine phosphorylated c-Cbl regulates platelet functional responses mediated by outside-in signaling.

Authors:  Lorena Buitrago; Wallace Y Langdon; Archana Sanjay; Satya P Kunapuli
Journal:  Blood       Date:  2011-10-03       Impact factor: 22.113

Review 4.  Regulation of Embryonic and Postnatal Development by the CSF-1 Receptor.

Authors:  Violeta Chitu; E Richard Stanley
Journal:  Curr Top Dev Biol       Date:  2016-12-01       Impact factor: 4.897

5.  Zap70 inhibits Syk-mediated osteoclast function.

Authors:  Wei Zou; Monica Croke; Tomohiro Fukunaga; Thomas J Broekelmann; Robert P Mecham; Steven L Teitelbaum
Journal:  J Cell Biochem       Date:  2013-08       Impact factor: 4.429

6.  Inhibition of CBLB protects from lethal Candida albicans sepsis.

Authors:  Gerald Wirnsberger; Florian Zwolanek; Tomoko Asaoka; Ivona Kozieradzki; Luigi Tortola; Reiner A Wimmer; Anoop Kavirayani; Friedrich Fresser; Gottfried Baier; Wallace Y Langdon; Fumiyo Ikeda; Karl Kuchler; Josef M Penninger
Journal:  Nat Med       Date:  2016-07-18       Impact factor: 53.440

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.